Form 8-K - Current report:
SEC Accession No. 0000950170-24-044096
Filing Date
2024-04-12
Accepted
2024-04-12 16:43:05
Documents
14
Period of Report
2024-04-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20240412.htm   iXBRL 8-K 51533
2 EX-5.1 tcon-ex5_1.htm EX-5.1 19650
3 GRAPHIC img259767944_0.jpg GRAPHIC 2120
4 GRAPHIC img259767944_1.jpg GRAPHIC 2120
  Complete submission text file 0000950170-24-044096.txt   195275

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240412.xsd EX-101.SCH 23907
17 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240412_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 24842049
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)